Universal selenium nanoadjuvant with immunopotentiating and redox-shaping activities inducing high-quality immunity for SARS-CoV-2 vaccine.
Signal Transduct Target Ther
; 8(1): 88, 2023 02 27.
Article
in En
| MEDLINE
| ID: mdl-36849546
Full text:
1
Database:
MEDLINE
Main subject:
Selenium
/
COVID-19
Language:
En
Journal:
Signal Transduct Target Ther
Year:
2023
Type:
Article
Affiliation country:
China